Table 5 Univariate and multivariate analysis of factors contributing to pad-free after RARP

Age (y.o.)

0.99 (0.97–1.01)

0.33

BMI (kg/m²)

0.96 (0.92–1.01)

0.13

Serum PSA (ng/mL)

0.98 (0.97-1.00)

0.048

0.99 (0.97-1.00)

0.17

Nerve sparing (Yes vs. No)

1.15 (0.82–1.57)

0.41

Lymph node dissection

(Yes vs. No)

0.77 (0.45–1.24)

0.32

Clinical T Stage

(≥ T3 vs. ≤ T2)

0.64 (0.42–0.94)

0.03

0.74 (0.48–1.10)

0.15

NCCN risk

(≥ high vs. ≤ intermediate)

0.91 (0.70–1.18)

0.49

Prostate volume (cm³)

1.00 (1.00–1.00)

0.10

Medication for BPH

(Yes vs. No)

1.29 (0.93–1.75)

0.11

Medication for DM

(Yes vs. No)

0.92 (0.64–1.30)

0.65

Taking AT agents

(Yes vs. No)

0.53 (0.36–0.74)

0.0004

0.55 (0.38–0.78)

0.001